Andreas Kjær

Andreas Kjær

Professor

ORCID: 0000-0002-2706-5547

Publication year:
All
51 - 53 out of 53Page size: 10
Sort by: Title
  1. Published

    64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection

    Loft, M., Carlsen, E. A., Johnbeck, C. B., Johannesen, Helle Hjorth, Binderup, Tina, Pfeifer, A., Mortensen, Jann, Oturai, P., Loft, A., Berthelsen, A. K., Langer, Seppo W., Knigge, U. & Kjær, Andreas, 2021, In: The Journal of Nuclear Medicine. 62, 1, p. 73-80 28 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    18F-FLT-PET/CT adds value to 18F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial

    Christensen, T. N., Langer, Seppo W., Persson, Gitte F., Larsen, Klaus Richter, Loft, A., Amtoft, A. G., Berthelsen, A. K., Johannesen, H. H., Keller, S. H., Kjær, Andreas & Fischer, Barbara Malene Bjerregaard, 2021, In: The Journal of Nuclear Medicine. 62, 5, p. 628-635 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients

    Binderup, Tina, Knigge, U., Johnbeck, C. B., Loft, A., Berthelsen, A. K., Oturai, P., Mortensen, Jann, Federspiel, B., Langer, Seppo W. & Kjær, Andreas, 2021, In: The Journal of Nuclear Medicine. 62, 6, p. 808-815 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 Next

ID: 13402